A member of the Bloomberg School of Public Health’s Department of Biochemistry and Molecular Biology, Dr. Bailey is focused on cellular structures and is responsible for breakthroughs in visualizing the atomic structure of a large multi-protein complex with a key role in bacterial immunity. It has set the stage for the development of new drugs to prevent antibiotic resistance and will foster progress in genome editing strategies that may someday lead to precision treatments for genetic disorders.
"As a researcher, Scott is incredibly gifted," says Pierre A. Coulombe, professor and chair of the Department of Biochemistry and Molecular Biology in the Bloomberg School. "He's bold in the choices he makes, but steady and poised as he is pursuing a question. He also has been a very strong mentor to his students."